Solicitation for Public Comments on Questions From the Task Force on Maternal Mental Health, 1110-1111 [2023-28890]
Download as PDF
<![CDATA[
1110
Federal Register / Vol. 89, No. 6 / Tuesday, January 9, 2024 / Notices
National Institutes of Health
National Institute of Dental &
Craniofacial Research; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Dental and Craniofacial Research; Special
Grants Review Committee.
Date: February 22–23, 2024.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Dental &
Craniofacial Research, 6701 Democracy
Blvd., Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Thomas John O’Farrell,
Ph.D., Scientific Review Officer, Scientific
Review Branch, Division of Extramural
Activities, National Institute of Dental &
Craniofacial Research, 6701 Democracy
Blvd., Bethesda, MD 20892, 301–402–8559,
tom.ofarrell@nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Dated: January 4, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–00249 Filed 1–8–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Solicitation for Public Comments on
Questions From the Task Force on
Maternal Mental Health
Office on Women’s Health,
Office of the Assistant Secretary for
Health, Office of the Secretary;
Substance Abuse and Mental Health
Services Administration (SAMHSA),
U.S. Department of Health and Human
Services (HHS)
ACTION: Notice of request for
information
khammond on DSKJM1Z7X2PROD with NOTICES
AGENCY:
VerDate Sep<11>2014
16:38 Jan 08, 2024
Jkt 262001
The Task Force on Maternal
Mental Health (Task Force), which is
being implemented as a subcommittee
of the SAMHSA Advisory Committee
for Women’s Services (ACWS), solicits
public comments on a set of questions
concerning the context, policies,
effectiveness, promising practices, and
limitations and gaps related to
prevention and treatment of maternal
mental health conditions and substance
use disorders (inclusive of alcohol use/
misuse) and its complications. The Task
Force is required to solicit public
comments, as appropriate, from
stakeholders for the purposes of
developing a report that analyzes and
evaluates the state of maternal mental
health programs at the Federal level and
identifies best practices with respect to
maternal mental health and substance
use disorders as well as a national
strategy for improving maternal mental
health. The taskforce will be
highlighting recommendations that fall
within the pregnancy and postpartum
(up to 1 year after birth) periods for
individuals with or at risk for mental
health and substance use conditions.
DATES: Electronic or written/paper
comments will be accepted through
midnight eastern standard time (EST)
January 31, 2024.
ADDRESSES: The set of questions is
available in the SUPPLEMENTARY
INFORMATION section below. Public
comments can be submitted in the
following ways:
• Electronic submissions can be filed
online at https://www.regulations.gov by
following the ‘‘Instructions for Public
Comments’’ section below. Comments
submitted electronically, including
attachments, will be posted to the
docket unchanged. Evidence and
information supporting your comment
can be submitted as attachments. Please
provide your contact information or
organization name on the web-based
form for follow up by the Task Force.
• If you prefer to comment on paper,
mail your comment to the following
address: 5600 Fishers Lane, Suite
18E01, Rockville, MD 20857. For mailed
submissions, OWH/SAMHSA will post
your comment, as well as any
attachments, to https://
www.regulations.gov.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket ID into the ‘‘Search’’ box and
follow the prompts.
FOR FURTHER INFORMATION CONTACT:
Valerie Kolick, Designated Federal
Officer, Advisory Committee for
SUMMARY:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
Women’s Services, U.S. Department of
Health and Human Services, Substance
Abuse and Mental Health Services
Administration, 5600 Fishers Lane,
Suite 18E01, Rockville, MD 20857.
Phone: 240–276–1738 or Email:
valerie.kolick@samhsa.hhs.gov.
SUPPLEMENTARY INFORMATION: Section
1113 of the Consolidated
Appropriations Act, 2023 (Pub. L. 117–
328) requires the HHS Secretary to
establish a Task Force on Maternal
Mental Health or incorporate the duties,
public meetings, and reports specified
into existing relevant Federal
committees or working groups. The
Task Force consists of representatives of
specific federal agencies and nonfederal individuals and entities who
represent diverse disciplines and views.
The Task Force will evaluate and make
recommendations to the ACWS for
further deliberation regarding
improvements and coordination for
Federal activities that address maternal
mental health and co-occurring
substance use disorders. The ACWS will
make final recommendations to the
Secretary of Health and Human Services
and to Congress.
The Task Force invites members of
the public to comment on any issues or
concerns they believe are relevant or
appropriate to the state of maternal
mental health programs at the Federal
level, and identification of best practices
with respect to maternal mental health
and substance use. Specifically, the
Task Force requests public comment on
the following questions:
1. Data, Research and Quality
Improvement:
• What are the priority outcomes for
pregnant and postpartum individuals
with substance use disorder and/or
mental health conditions?
• How would you define quality care
for pregnant and postpartum
individuals with substance use
disorders and/or mental health
conditions?
• What are the priority research
questions and gaps related to maternal
substance use disorder and/or mental
health conditions that must be
addressed to improve services and
outcomes for individuals while
pregnant and postpartum?
2. Prevention, Screening and
Diagnosis:
• What is lacking and what is
working to support maternal emotional
health, and substance use and wellbeing during pregnancy and after?
• What steps should be taken to
ensure that approaches to detecting
maternal emotional health issues and
substance use challenges are culturally
appropriate?
E:\FR\FM\09JAN1.SGM
09JAN1
khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 89, No. 6 / Tuesday, January 9, 2024 / Notices
• What can be done to help pregnant
and postpartum individuals feel more
comfortable to open up about how they
are feeling? Who, where, and how might
pregnant and postpartum individuals
feel safest about disclosing their
experience?
3. Evidence-based Intervention and
Treatment:
• What are key evidence-based
intervention and treatment models that
should be broadly implemented to
address maternal mental health and
substance use?
i. Do providers have the training and
resources to appropriately provide
evidenced-based intervention and
treatment or referral?
ii. Are community-based resources
being utilized to bridge the gap in
education, evidence-based screening,
and treatment or referral? If not, what
are the challenges of incorporating
culturally competent community-based
health care workers?
• What are the barriers/gaps to
evidence-based intervention for
maternal mental health and substance
use among reproductive age
individuals? How do access and
engagement differ between people who
have already received mental health
and/or substance use treatment prior to
pregnancy versus those who never
have?
• Are underserved populations
represented in the research and
subsequent guidelines developed from
the research for screening and
treatment? What evidence is still needed
to inform guidelines for screening and
treatment, including for
underrepresented, underserved
populations?
i. Underserved populations may
include Black, Latino, and Indigenous
and American Indian/Alaska Native
persons, Asian Americans and Pacific
Islanders and other persons of color;
members of religious minorities;
lesbian, gay, bisexual, transgender,
queer, and intersex (LGBTQI+) persons;
persons with disabilities; persons who
live in rural areas; and persons
otherwise adversely affected by
persistent poverty or inequality.
4. Evidence-Based Community
Practices:
• What are the most pressing needs
related to maternal mental health and
maternal substance use in your
community? For the purposes of this
question, please define ‘‘community’’
however it most resonates with you
(e.g., geography, race, ethnicity, sexual
orientation, and gender identity,
disability status, American Indian/
Alaska Native status, veteran status,
etc.)
VerDate Sep<11>2014
16:38 Jan 08, 2024
Jkt 262001
• What strategies have been the most
successful, transformative, and/or
sustainable in addressing maternal
mental health and maternal substance
use needs in your community? What
strategies have been the least successful,
transformative, and/or sustainable, and
why?
• What innovations are needed to
better address maternal mental health
and substance use needs in your
community (i.e., how can communitybased organizations and entrepreneurs
partner to address gaps and provide
support for areas of identified need)?
5. Communications and Community
Engagement:
• What do ideal services and
resources look like for a pregnant or
postpartum individual in your
community? And what are barriers to
access to these services?
• What steps should be taken to
ensure that approaches to detecting
maternal emotional health issues and
substance use challenges are culturally
appropriate?
• What can be done to help mothers
and pregnant and postpartum people
feel more comfortable to open up about
how they are feeling? Who, where, and
how might mothers and pregnant and
postpartum people feel safest about
disclosing their experience?
How to submit a response: All
submissions must be submitted in the
Docket ID HHS- for ‘‘Solicitation for
Public Comments on Questions from the
Task Force on Maternal Mental Health.’’
Comments are encouraged from the
public and will be accepted through
January 31, 2024. The https://
www.regulations.gov electronic filing
system will accept electronic comments
until midnight eastern time at the end
of January 31, 2024. Comments received
by mail/courier will be considered if
they are postmarked or the delivery
service acceptance receipt date is on or
before that date. Written comments via
mail will be uploaded into https://
www.regulations.gov and are under the
same limitations as for those directly
submitted electronically into https://
www.regulations.gov: 5,000 character
limit for text box, and maximum
number (10) of attached files and
maximum size (10 MB) of each attached
file.
This RFI is for informational and
planning purposes only and is not a
solicitation for applications or an
obligation on the part of the
Government to provide support for any
ideas identified in response to it. Please
note that the Government will not pay
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
1111
for the preparation of any information
submitted or for use of that information.
Alicia Broadus,
Public Health Advisor.
[FR Doc. 2023–28890 Filed 1–8–24; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No. USCG–2023–0674]
National Maritime Security Advisory
Committee; February 2024 Meeting
United States Coast Guard
(USCG), Department of Homeland
Security (DHS).
ACTION: Notice of open Federal advisory
committee meeting.
AGENCY:
The National Maritime
Security Advisory Committee
(Committee) will conduct a series of
meetings over three days in conjunction
with the 11th Annual Maritime Security
East Conference in Arlington, VA to
discuss the Committee’s open taskings
concerning NVIC 03–03 updates, Active
Shooter/Active Threat in the Maritime
Environment, and Unmanned Systems
in the Maritime Environment. All
meetings will be open to the public and
will not require registration to the
Conference.
SUMMARY:
DATES:
Meetings: The Committee will meet
on Monday, February 5, 2024, from 1:40
p.m. until 3:40 p.m. Eastern Standard
Time (EST), Tuesday, February 6, 2024,
from 10 a.m. until noon (EST), and on
Wednesday, February 7, 2024, from
10:15 a.m. until 12:15 p.m. (EST). Please
note these meetings may close early if
the Committee has completed its
business.
Comments and supporting
documentation: To ensure your
comments are received by Committee
members before the meetings, submit
your written comments no later than
February 1, 2024.
ADDRESSES: The meetings will be held
in the Tidewater II conference room at
the Hyatt Regency Crystal City, 2799
Richmond Highway, Arlington, VA
22202, website Crystal City, VA Hotels
Near DCA | Hyatt Regency Crystal City
at Reagan National Airport. The
meetings will also be held virtually. To
join the virtual meetings or to request
special accommodations, contact the
individual listed in the FOR FURTHER
INFORMATION CONTACT section no later
than 1 p.m. EST on February 1, 2024, to
E:\FR\FM\09JAN1.SGM
09JAN1
]]>Agencies
[Federal Register Volume 89, Number 6 (Tuesday, January 9, 2024)]
[Notices]
[Pages 1110-1111]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-28890]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Solicitation for Public Comments on Questions From the Task Force
on Maternal Mental Health
AGENCY: Office on Women's Health, Office of the Assistant Secretary for
Health, Office of the Secretary; Substance Abuse and Mental Health
Services Administration (SAMHSA), U.S. Department of Health and Human
Services (HHS)
ACTION: Notice of request for information
-----------------------------------------------------------------------
SUMMARY: The Task Force on Maternal Mental Health (Task Force), which
is being implemented as a subcommittee of the SAMHSA Advisory Committee
for Women's Services (ACWS), solicits public comments on a set of
questions concerning the context, policies, effectiveness, promising
practices, and limitations and gaps related to prevention and treatment
of maternal mental health conditions and substance use disorders
(inclusive of alcohol use/misuse) and its complications. The Task Force
is required to solicit public comments, as appropriate, from
stakeholders for the purposes of developing a report that analyzes and
evaluates the state of maternal mental health programs at the Federal
level and identifies best practices with respect to maternal mental
health and substance use disorders as well as a national strategy for
improving maternal mental health. The taskforce will be highlighting
recommendations that fall within the pregnancy and postpartum (up to 1
year after birth) periods for individuals with or at risk for mental
health and substance use conditions.
DATES: Electronic or written/paper comments will be accepted through
midnight eastern standard time (EST) January 31, 2024.
ADDRESSES: The set of questions is available in the SUPPLEMENTARY
INFORMATION section below. Public comments can be submitted in the
following ways:
Electronic submissions can be filed online at https://www.regulations.gov by following the ``Instructions for Public
Comments'' section below. Comments submitted electronically, including
attachments, will be posted to the docket unchanged. Evidence and
information supporting your comment can be submitted as attachments.
Please provide your contact information or organization name on the
web-based form for follow up by the Task Force.
If you prefer to comment on paper, mail your comment to
the following address: 5600 Fishers Lane, Suite 18E01, Rockville, MD
20857. For mailed submissions, OWH/SAMHSA will post your comment, as
well as any attachments, to https://www.regulations.gov.
Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket ID into the ``Search'' box
and follow the prompts.
FOR FURTHER INFORMATION CONTACT: Valerie Kolick, Designated Federal
Officer, Advisory Committee for Women's Services, U.S. Department of
Health and Human Services, Substance Abuse and Mental Health Services
Administration, 5600 Fishers Lane, Suite 18E01, Rockville, MD 20857.
Phone: 240-276-1738 or Email: [email protected].
SUPPLEMENTARY INFORMATION: Section 1113 of the Consolidated
Appropriations Act, 2023 (Pub. L. 117-328) requires the HHS Secretary
to establish a Task Force on Maternal Mental Health or incorporate the
duties, public meetings, and reports specified into existing relevant
Federal committees or working groups. The Task Force consists of
representatives of specific federal agencies and non-federal
individuals and entities who represent diverse disciplines and views.
The Task Force will evaluate and make recommendations to the ACWS for
further deliberation regarding improvements and coordination for
Federal activities that address maternal mental health and co-occurring
substance use disorders. The ACWS will make final recommendations to
the Secretary of Health and Human Services and to Congress.
The Task Force invites members of the public to comment on any
issues or concerns they believe are relevant or appropriate to the
state of maternal mental health programs at the Federal level, and
identification of best practices with respect to maternal mental health
and substance use. Specifically, the Task Force requests public comment
on the following questions:
1. Data, Research and Quality Improvement:
What are the priority outcomes for pregnant and postpartum
individuals with substance use disorder and/or mental health
conditions?
How would you define quality care for pregnant and
postpartum individuals with substance use disorders and/or mental
health conditions?
What are the priority research questions and gaps related
to maternal substance use disorder and/or mental health conditions that
must be addressed to improve services and outcomes for individuals
while pregnant and postpartum?
2. Prevention, Screening and Diagnosis:
What is lacking and what is working to support maternal
emotional health, and substance use and well-being during pregnancy and
after?
What steps should be taken to ensure that approaches to
detecting maternal emotional health issues and substance use challenges
are culturally appropriate?
[[Page 1111]]
What can be done to help pregnant and postpartum
individuals feel more comfortable to open up about how they are
feeling? Who, where, and how might pregnant and postpartum individuals
feel safest about disclosing their experience?
3. Evidence-based Intervention and Treatment:
What are key evidence-based intervention and treatment
models that should be broadly implemented to address maternal mental
health and substance use?
i. Do providers have the training and resources to appropriately
provide evidenced-based intervention and treatment or referral?
ii. Are community-based resources being utilized to bridge the gap
in education, evidence-based screening, and treatment or referral? If
not, what are the challenges of incorporating culturally competent
community-based health care workers?
What are the barriers/gaps to evidence-based intervention
for maternal mental health and substance use among reproductive age
individuals? How do access and engagement differ between people who
have already received mental health and/or substance use treatment
prior to pregnancy versus those who never have?
Are underserved populations represented in the research
and subsequent guidelines developed from the research for screening and
treatment? What evidence is still needed to inform guidelines for
screening and treatment, including for underrepresented, underserved
populations?
i. Underserved populations may include Black, Latino, and
Indigenous and American Indian/Alaska Native persons, Asian Americans
and Pacific Islanders and other persons of color; members of religious
minorities; lesbian, gay, bisexual, transgender, queer, and intersex
(LGBTQI+) persons; persons with disabilities; persons who live in rural
areas; and persons otherwise adversely affected by persistent poverty
or inequality.
4. Evidence-Based Community Practices:
What are the most pressing needs related to maternal
mental health and maternal substance use in your community? For the
purposes of this question, please define ``community'' however it most
resonates with you (e.g., geography, race, ethnicity, sexual
orientation, and gender identity, disability status, American Indian/
Alaska Native status, veteran status, etc.)
What strategies have been the most successful,
transformative, and/or sustainable in addressing maternal mental health
and maternal substance use needs in your community? What strategies
have been the least successful, transformative, and/or sustainable, and
why?
What innovations are needed to better address maternal
mental health and substance use needs in your community (i.e., how can
community-based organizations and entrepreneurs partner to address gaps
and provide support for areas of identified need)?
5. Communications and Community Engagement:
What do ideal services and resources look like for a
pregnant or postpartum individual in your community? And what are
barriers to access to these services?
What steps should be taken to ensure that approaches to
detecting maternal emotional health issues and substance use challenges
are culturally appropriate?
What can be done to help mothers and pregnant and
postpartum people feel more comfortable to open up about how they are
feeling? Who, where, and how might mothers and pregnant and postpartum
people feel safest about disclosing their experience?
How to submit a response: All submissions must be submitted in the
Docket ID HHS- for ``Solicitation for Public Comments on Questions from
the Task Force on Maternal Mental Health.'' Comments are encouraged
from the public and will be accepted through January 31, 2024. The
https://www.regulations.gov electronic filing system will accept
electronic comments until midnight eastern time at the end of January
31, 2024. Comments received by mail/courier will be considered if they
are postmarked or the delivery service acceptance receipt date is on or
before that date. Written comments via mail will be uploaded into
https://www.regulations.gov and are under the same limitations as for
those directly submitted electronically into https://www.regulations.gov: 5,000 character limit for text box, and maximum
number (10) of attached files and maximum size (10 MB) of each attached
file.
This RFI is for informational and planning purposes only and is not
a solicitation for applications or an obligation on the part of the
Government to provide support for any ideas identified in response to
it. Please note that the Government will not pay for the preparation of
any information submitted or for use of that information.
Alicia Broadus,
Public Health Advisor.
[FR Doc. 2023-28890 Filed 1-8-24; 8:45 am]
BILLING CODE 4162-20-P
